Written answers

Tuesday, 5 July 2016

Department of Health

Drugs Payment Scheme Coverage

Photo of Peter BurkePeter Burke (Longford-Westmeath, Fine Gael)
Link to this: Individually | In context | Oireachtas source

515. To ask the Minister for Health if he will fund the drug Ampligen for suffers of myalgic encephalomyelitis; and if he will make a statement on the matter. [19325/16]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Prior to reimbursing any item, the HSE considers a range of statutory criteria, including clinical need, cost-effectiveness and the resources available.

The holder of a market authorisation for a product may apply to the HSE to have the product reimbursed in Ireland. The HSE has advised that it does not currently have an application for reimbursement of the drug in question.

Comments

No comments

Log in or join to post a public comment.